| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation
|
Pullarkat, V.
|
|
|
20 |
12 |
p. 2000-2006
|
artikel
|
| 2 |
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67
|
Hahn, N.M.
|
|
|
20 |
12 |
p. 1971-1976
|
artikel
|
| 3 |
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
|
Ychou, M.
|
|
|
20 |
12 |
p. 1964-1970
|
artikel
|
| 4 |
Are we representing the true population in oncology trials?
|
Lord, S.R.
|
|
|
20 |
12 |
p. 2022
|
artikel
|
| 5 |
Bone morphogenetic proteins and zoledronic acid
|
Sahin, U.
|
|
|
20 |
12 |
p. 2019
|
artikel
|
| 6 |
Clinician versus nurse symptom reporting using the National Cancer Institute—Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire
|
Cirillo, M.
|
|
|
20 |
12 |
p. 1929-1935
|
artikel
|
| 7 |
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
|
Arnedos, M.
|
|
|
20 |
12 |
p. 1948-1952
|
artikel
|
| 8 |
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE
|
de la Fouchardière, C.
|
|
|
20 |
12 |
p. 1959-1963
|
artikel
|
| 9 |
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case–control retrospective analysis
|
Delgado, J.
|
|
|
20 |
12 |
p. 2007-2012
|
artikel
|
| 10 |
Drug interactions in oncology: how common are they?
|
Riechelmann, R.P.
|
|
|
20 |
12 |
p. 1907-1912
|
artikel
|
| 11 |
Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies
|
De Cicco, M.
|
|
|
20 |
12 |
p. 1936-1942
|
artikel
|
| 12 |
Editorial board
|
|
|
|
20 |
12 |
p. ii-iii
|
artikel
|
| 13 |
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
|
Nickelsen, M.
|
|
|
20 |
12 |
p. 1977-1984
|
artikel
|
| 14 |
in this issue
|
|
|
|
20 |
12 |
p. 1903
|
artikel
|
| 15 |
Patient-reported outcomes in drug safety evaluation
|
Basch, E.
|
|
|
20 |
12 |
p. 1905-1906
|
artikel
|
| 16 |
Phase I/II clinical study of percutaneous vertebroplasty (PVP) as palliation for painful malignant vertebral compression fractures (PMVCF): JIVROSG-0202
|
Kobayashi, T.
|
|
|
20 |
12 |
p. 1943-1947
|
artikel
|
| 17 |
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group
|
Martinelli, G.
|
|
|
20 |
12 |
p. 1993-1999
|
artikel
|
| 18 |
Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
|
Liedtke, C.
|
|
|
20 |
12 |
p. 1953-1958
|
artikel
|
| 19 |
Rapid progression of hormone receptor-negative breast cancer concomitant with ovarian stimulation—a paradoxon?
|
Pukrop, T.
|
|
|
20 |
12 |
p. 2020-2022
|
artikel
|
| 20 |
Reply to Are we representing the true population in oncology trials?
|
Kang, Y.-K.
|
|
|
20 |
12 |
p. 2022-2023
|
artikel
|
| 21 |
Reply to Bone morphogenetic proteins and zoledronic acid
|
Bertagna, X.
|
|
|
20 |
12 |
p. 2019
|
artikel
|
| 22 |
Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier
|
Fukushima, N.
|
|
|
20 |
12 |
p. 2013-2017
|
artikel
|
| 23 |
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma
|
Haioun, C.
|
|
|
20 |
12 |
p. 1985-1992
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
20 |
12 |
p. iv-v
|
artikel
|
| 25 |
Triple-negative breast cancer—current status and future directions
|
Gluz, O.
|
|
|
20 |
12 |
p. 1913-1927
|
artikel
|
| 26 |
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen
|
Vignani, F.
|
|
|
20 |
12 |
p. 2019-2020
|
artikel
|
Tijdschrift beschrijving